Received Feb 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | — | — |
My daughter, who is currently 9 years old, received her first dose of Varivax at 15 months of age; however, she has not yet received the second dose; No additional AE/; This spontaneous report was received from a Consumer and refers to a female patient of unknown age (the reporter's daughter). The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with the 1st dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (dose, route and site of administration, formulation, lot # and expiration date were not reported) for prophylaxis. At the time of the report, the patient, who was at that point 9 years old, has not yet received the second dose (inappropriate schedule of product administration). No additional adverse event (AE) was reported (no adverse event). Lot # is being requested and will be submitted if received.